Literature DB >> 20227872

EORTC elderly task force position paper: approach to the older cancer patient.

A G Pallis1, C Fortpied, U Wedding, M C Van Nes, B Penninckx, A Ring, D Lacombe, S Monfardini, P Scalliet, H Wildiers.   

Abstract

As a result of an increasing life expectancy, the incidence of cancer cases diagnosed in the older population is rising. Indeed, cancer incidence is 11-fold higher in persons over the age of 65 than in younger ones. Despite this high incidence of cancer in older patients, solid data regarding the most appropriate approach and best treatment for older cancer patients are still lacking, mostly due to under-representation of these patients in prospective clinical trials. The clinical behaviour of common malignant diseases, e.g. breast, ovarian and lung cancers, lymphomas and acute leukaemias, may be different in older patients because of intrinsic variation of the neoplastic cells and the ability of the tumour host to support neoplastic growth. The decision to treat or not these patients should be based on patients' functional age rather than the chronological age. Assessment of patients' functional age includes the evaluation of health, functional status, nutrition, cognition and the psychosocial and economic context. The purpose of this paper is to focus on the influence of age on cancer presentation and cancer management in older cancer patients and to provide suggestions on clinical trial development and methodology in this population. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20227872     DOI: 10.1016/j.ejca.2010.02.022

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  86 in total

Review 1.  Challenges in the management of older patients with colon cancer.

Authors:  Efrat Dotan; Ilene Browner; Arti Hurria; Crystal Denlinger
Journal:  J Natl Compr Canc Netw       Date:  2012-02       Impact factor: 11.908

Review 2.  Targeted Therapies in the Management of Ovarian Cancer: A Focus on Older Patients.

Authors:  Caroline Lum; Christopher B Steer
Journal:  Drugs Aging       Date:  2017-11       Impact factor: 3.923

Review 3.  Systemic therapies for metastatic renal cell carcinoma in older adults.

Authors:  Sumanta K Pal; Ari Vanderwalde; Arti Hurria; Robert A Figlin
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

Review 4.  [Prediction of unplanned discontinuation of treatment in patients with castration-resistant prostate cancer-results from the IBuTu study].

Authors:  F Honecker; U Wedding; G Kallischnigg; A Schroeder; J Klier; T Frangenheim; L Weißbach
Journal:  Urologe A       Date:  2018-08       Impact factor: 0.639

5.  Quality of life in elderly breast cancer patients with localized disease receiving endocrine treatment: a prospective study.

Authors:  J I Arraras; J J Illarramendi; A Manterola; G Asin; E Salgado; P Arrondo; M A Dominguez; V Arrazubi; E Martinez; A Viudez; S de la Cruz; R Vera
Journal:  Clin Transl Oncol       Date:  2019-02-02       Impact factor: 3.405

6.  The eight-item modified Medical Outcomes Study Social Support Survey: psychometric evaluation showed excellent performance.

Authors:  André Moser; Andreas E Stuck; Rebecca A Silliman; Patricia A Ganz; Kerri M Clough-Gorr
Journal:  J Clin Epidemiol       Date:  2012-07-20       Impact factor: 6.437

Review 7.  Present status of adjuvant chemotherapy for elderly breast cancer patients.

Authors:  Sibylle Loibl; Mattea Reinisch
Journal:  Breast Care (Basel)       Date:  2012-12       Impact factor: 2.860

8.  Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Mark Zaki; Michael Dominello; Gregory Dyson; Shirish Gadgeel; Antoinette Wozniak; Steven Miller; Peter Paximadis
Journal:  Clin Lung Cancer       Date:  2016-07-22       Impact factor: 4.785

9.  Skin rash during cetuximab treatment in advanced colorectal cancer: is age a clinical predictor?

Authors:  Jacopo Giuliani; Marina Marzola
Journal:  J Gastrointest Cancer       Date:  2013-06

10.  [Geriatric assessment prior to oncological therapy].

Authors:  U Wedding
Journal:  Urologe A       Date:  2013-06       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.